MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: Nov 20, 2025
Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers
Commissioning Completed for Expanded NexoBrid® Facility; Full Operational Capacity Expected by Year-End 2025
Read more at globenewswire.com
